0001438133-23-000080.txt : 20230517
0001438133-23-000080.hdr.sgml : 20230517
20230517180839
ACCESSION NUMBER: 0001438133-23-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leal James
CENTRAL INDEX KEY: 0001866570
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 23933179
MAIL ADDRESS:
STREET 1: C/O TANDEM DIABETES CARE, INC.
STREET 2: 11075 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
4
1
wf-form4_168436130062849.xml
FORM 4
X0407
4
2023-05-15
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001866570
Leal James
12400 HIGH BLUFF DRIVE
SAN DIEGO
CA
92130
0
1
0
0
Chief Manufacturing Officer
0
Common Stock
2023-05-15
4
A
0
621
27.32
A
6427
D
Common Stock
2023-05-15
4
M
0
168
0
A
6595
D
Common Stock
2023-05-15
4
F
0
70
32.13
D
6525
D
Common Stock
2023-05-15
4
M
0
3223
0
A
9748
D
Common Stock
2023-05-15
4
F
0
1333
32.13
D
8415
D
Restricted Stock Unit
2023-05-15
4
M
0
168
0
D
Common Stock
168.0
1340
D
Restricted Stock Unit
2023-05-15
4
M
0
3223
0
D
Common Stock
3223.0
6446
D
Restricted Stock Unit
2023-05-15
4
A
0
6898
0
A
Common Stock
6898.0
13796
D
The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).
Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.
RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.
RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.
/s/ Rachel Malina, Attorney-in-Fact for James A. Leal
2023-05-17